Details of Protein
| General Information of Protein (ID: PRT00286) | |||||
|---|---|---|---|---|---|
| Name | Dihydrodipicolinate synthase-like (DHDPSL) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
4-hydroxy-2-oxoglutarate aldolase, mitochondrial; DHDPS-like protein; Probable 2-keto-4-hydroxyglutarate aldolase; Probable KHG-aldolase; Protein 569272; HOGA1; C10orf65
|
||||
| Gene Name | HOGA1 | Gene ID | |||
| UniProt ID | |||||
| Family | Lyases (EC 4) | ||||
| EC Number | EC: 4.1.3.16 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MLGPQVWSSVRQGLSRSLSRNVGVWASGEGKKVDIAGIYPPVTTPFTATAEVDYGKLEEN
LHKLGTFPFRGFVVQGSNGEFPFLTSSERLEVVSRVRQAMPKNRLLLAGSGCESTQATVE MTVSMAQVGADAAMVVTPCYYRGRMSSAALIHHYTKVADLSPIPVVLYSVPANTGLDLPV DAVVTLSQHPNIVGMKDSGGDVTRIGLIVHKTRKQDFQVLAGSAGFLMASYALGAVGGVC ALANVLGAQVCQLERLCCTGQWEDAQKLQHRLIEPNAAVTRRFGIPGLKKIMDWFGYYGG PCRAPLQELSPAEEEALRMDFTSNGWL |
||||
| Structure | |||||
| Function | Catalyzes the final step in the metabolic pathway of hydroxyproline. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Lipids and lipid-like molecules | ||||||
| 2,4-Dihydroxyglutarate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: bi-allelic mutations) of HOGA1 | |||||
| Induced Change | 2,4-Dihydroxyglutarate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with bi-allelic mutations) of HOGA1 leads to the increase of 2,4-dihydroxyglutarate levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| 4-Hydroxy-L-glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: bi-allelic mutations) of HOGA1 | |||||
| Induced Change | 4-Hydroxy-L-glutamic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with bi-allelic mutations) of HOGA1 leads to the increase of 4-hydroxy-L-glutamic acid levels compared with control group. | |||||
| D-4-Hydroxy-2-oxoglutarate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: bi-allelic mutations) of HOGA1 | |||||
| Induced Change | D-4-Hydroxy-2-oxoglutarate concentration: increase (FC = 50) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with bi-allelic mutations) of HOGA1 leads to the increase of D-4-hydroxy-2-oxoglutarate levels compared with control group. | |||||
| Oxalic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: bi-allelic mutations) of HOGA1 | |||||
| Induced Change | Oxalic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with bi-allelic mutations) of HOGA1 leads to the increase of oxalic acid levels compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism. J Mol Med (Berl). 2012 Dec;90(12):1497-504. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

